Literature DB >> 21813492

The NIMH-CATIE Schizophrenia Study: what did we learn?

Jeffrey A Lieberman, T Scott Stroup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813492     DOI: 10.1176/appi.ajp.2011.11010039

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  29 in total

Review 1.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

2.  Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.

Authors:  Seema Jain; Rebecca Andridge; Jessica A Hellings
Journal:  J Autism Dev Disord       Date:  2016-04

Review 3.  Using model systems to understand errant plasticity mechanisms in psychiatric disorders.

Authors:  Bruno B Averbeck; Matthew V Chafee
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

4.  Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.

Authors:  Charles M Richardson; Erica A Davis; Gopal R Vyas; Bethany A DiPaula; Robert P McMahon; Deanna L Kelly
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

5.  Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo.

Authors:  Lingyan Shi; Min Zeng; Bingmei M Fu
Journal:  J Neurosci Res       Date:  2014-07-28       Impact factor: 4.164

6.  Changes in physician antipsychotic prescribing preferences, 2002-2007.

Authors:  Julie Donohue; A James O'Malley; Marcela Horvitz-Lennon; Anna Levine Taub; Ernst R Berndt; Haiden A Huskamp
Journal:  Psychiatr Serv       Date:  2014-03-01       Impact factor: 3.084

7.  A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital.

Authors:  Karan B Thakkar; Mangal M Jain; Gauri Billa; Abhijit Joshi; Akash A Khobragade
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 8.  Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Authors:  Nancy Sohler; Ben G Adams; David M Barnes; Gregory H Cohen; Seth J Prins; Sharon Schwartz
Journal:  Am J Orthopsychiatry       Date:  2015-12-14

9.  A risperidone-induced prolactinoma resolved when a woman with schizoaffective disorder switched to ziprasidone: a case report.

Authors:  Gail T Arcari; Asante K Mendes; Robert B Sothern
Journal:  Innov Clin Neurosci       Date:  2012-09

Review 10.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.